Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP21501.RAPDw0oGRB8BvxicWgyV07M22JKMkLiO6teIB4JdGumJs130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_curated type ECO_0000205 NP21501.RAPDw0oGRB8BvxicWgyV07M22JKMkLiO6teIB4JdGumJs130_provenance.
- source_evidence_curated label "DisGeNET evidence - CURATED" NP21501.RAPDw0oGRB8BvxicWgyV07M22JKMkLiO6teIB4JdGumJs130_provenance.
- source_evidence_curated comment "Gene-disease associations manually curated." NP21501.RAPDw0oGRB8BvxicWgyV07M22JKMkLiO6teIB4JdGumJs130_provenance.
- NP21501.RAPDw0oGRB8BvxicWgyV07M22JKMkLiO6teIB4JdGumJs130_assertion description "[Attenuation of MAP3K9 function in melanoma cells using siRNA led to increased cell viability after temozolomide treatment, suggesting that decreased MAP3K pathway activity can lead to chemoresistance in melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP21501.RAPDw0oGRB8BvxicWgyV07M22JKMkLiO6teIB4JdGumJs130_provenance.
- NP21501.RAPDw0oGRB8BvxicWgyV07M22JKMkLiO6teIB4JdGumJs130_assertion evidence source_evidence_curated NP21501.RAPDw0oGRB8BvxicWgyV07M22JKMkLiO6teIB4JdGumJs130_provenance.
- NP21501.RAPDw0oGRB8BvxicWgyV07M22JKMkLiO6teIB4JdGumJs130_assertion SIO_000772 22197930 NP21501.RAPDw0oGRB8BvxicWgyV07M22JKMkLiO6teIB4JdGumJs130_provenance.
- NP21501.RAPDw0oGRB8BvxicWgyV07M22JKMkLiO6teIB4JdGumJs130_assertion wasDerivedFrom ctd_human-20150221 NP21501.RAPDw0oGRB8BvxicWgyV07M22JKMkLiO6teIB4JdGumJs130_provenance.
- NP21501.RAPDw0oGRB8BvxicWgyV07M22JKMkLiO6teIB4JdGumJs130_assertion wasGeneratedBy ECO_0000218 NP21501.RAPDw0oGRB8BvxicWgyV07M22JKMkLiO6teIB4JdGumJs130_provenance.
- ctd_human-20150221 importedOn "2015-02-21" NP21501.RAPDw0oGRB8BvxicWgyV07M22JKMkLiO6teIB4JdGumJs130_provenance.